Krystal Biotech Inc

KRYS · NASDAQ

Biological Product (except Diagnostic) Manufacturing

Krystal Biotech, Inc. is a pivotal-stage gene therapy company leveraging its novel, redosable gene therapy platform and in-house manufacturing capabilities to develop therapies to treat serious rare diseases.

ESG Scores

Overall ESG

5.0

Environmental

6.4

Social

4.0

Governance

5.0

Gender Diversity

Female Directors0.22219999999999998%

Female Executives0.28378378378378377%

CEO GenderMale

Market Data

Price$276.50+2.29 (+0.84%)

Market Cap$8.02B

P/E Ratio39.13

EPS$—

52W High$298.30

52W Low$122.80

Beta0.53